FAPi-PET/CT作为亚临床心肌纤维化替代标志物可预测左侧心脏瓣膜手术患者预后
本研究评估FAP靶向PET/CT作为心脏纤维化替代标志物对左侧瓣膜性心脏病开放手术患者的预后价值。13例拟行主动脉瓣和/或二尖瓣手术患者术前接受[68Ga]Ga-RTX1363S FAPi-PET/CT,以等轮廓55%阈值量化的FAP阳性体积与术前LVEF(p=0.03)、NT-proBNP(p=0.02)及术后3–6个月LVEF变化(p=0.04)显著相关。结论提示术前FAPi-PET/CT有潜力预测瓣膜术后LVEF变化并用于风险分层。
要点
- 等轮廓55%阈值量化的FAP阳性体积与术前LVEF、NT-proBNP显著相关
- FAP阳性体积与术后3–6个月LVEF变化显著相关(p=0.04)
- FAPi-PET/CT有望辅助无症状左侧瓣膜病患者手术时机决策
核心结论
- 术前FAPi-PET/CT似乎有潜力预测瓣膜性心脏手术后LVEF变化,并可能成为左侧瓣膜性心脏病无症状患者风险分层及手术时机决策的重要工具。
研究设计与样本
- 单中心研究纳入13例拟行主动脉瓣和/或二尖瓣手术患者(男6例、女7例,平均年龄62±13岁),术前行[68Ga]Ga-RTX1363S FAPi-PET/CT。
- 采用固定阈值和可变阈值的等轮廓法量化FAP阳性体积与FAP摄取,并与术前临床参数及术后3–6个月LVEF变化(11例可获取随访)进行相关性分析。
主要发现
- 研究队列中左心室心肌FAP摄取高度可变。
- 基于等轮廓55%的FAP阳性体积与术前LVEF显著相关(p=0.03)。
- 基于等轮廓55%的FAP阳性体积与术前NT-proBNP显著相关(p=0.02)。
- 基于等轮廓55%的FAP阳性体积与术前至术后3–6个月随访LVEF变化显著相关(p=0.04)。
关键数值与推荐
- 以等轮廓55%阈值量化的FAP阳性体积与术前LVEF相关(p=0.03)。
- 以等轮廓55%阈值量化的FAP阳性体积与术前NT-proBNP相关(p=0.02)。
- 以等轮廓55%阈值量化的FAP阳性体积与术前至术后3–6个月LVEF变化相关(p=0.04)。
临床怎么用
- 对拟行左侧瓣膜手术患者,术前可考虑FAPi-PET/CT量化心肌FAP阳性体积以辅助评估心肌纤维化负荷。
- 等轮廓55%阈值量化的FAP阳性体积或可用于预测术后LVEF变化,辅助无症状患者手术时机决策。
局限性
- 样本量小(13例),随访LVEF仅11例可获取。
- 研究为单中心探索性分析,FAP摄取在队列中高度可变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to evaluate fibroblast activation protein (FAP)-targeted positron emission tomography and computed tomography (PET/CT) imaging as surrogate marker for cardiac fibrosis and therefore as prognostic tool for patients with left-sided valvular heart disease undergoing open-heart surgery. RESULTS: In 13 patients (6 men, 7 women; mean age ± SD, 62 ± 13 years) scheduled for aortic and/or mitral valve surgery (aortic, n = 3; mitral, n = 9; both, n = 1) preoperative FAPi-PET/CT ([68Ga]Ga-RTX1363S) was perfomred. FAP-positive volume and FAP uptake was quantified by different methods (isocontour with fixed and variable threshold) and correlated to preoperative clinical parameters, including (left ventricular ejection fraction (LVEF) and serum N-terminal prohormone of brain natriuretic peptide (NT-proBNP), as well as to changes in LVEF from preoperatively to 3–6 months follow-up (available for n = 11 patients). FAP-uptake in the left ventricular (LV) myocardium was highly variable in the study cohort. Isocontour-55%-based FAP-positive volume was found to correlate statistically significantly with preoperative LVEF (p = 0.03) and preoperative NT-proBNP (p = 0.02). In addition, we found a significant correlation with the change in LVEF from preoperatively to 3–6 months follow-up examination (p = 0.04). CONCLUSIONS: Preoperative FAPi PET/CT seems to have potential to predict LVEF changes after valvular heart surgery and may therefore be an important tool for risk stratification of asymptomatic patients with left-sided valvular heart disease to support the appropriate timing of valvular surgery.
引用
- Holst T, Dierks A, Patt M, et al. FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery. EJNMMI Res. 2026. PMID: 41931251. doi:10.1186/s13550-025-01324-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。